Evaluation of the dose calculation accuracy in intensity-modulated radiation therapy for mesothelioma, focusing on low doses to the contralateral lung

Journal of Applied Clinical Medical Physics

Volumn 10, Issue 2, 2009, Pages 34-42

  Court, Laurence E ^a   Ching, David ^a   Schofield, Deborah ^a   Czerminska, Maria ^a   Allen, Aaron M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

IMRT; Mesothelioma; Monte Carlo

Indexed keywords

EID: 69949157298     PISSN: None     EISSN: 15269914     Source Type: Journal    
DOI: 10.1120/jacmp.v10i2.2850     Document Type: Article

References (29)

1. Ahamad A, Stevens CW, Smythe WR, et al. Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest. Cancer J. 2003;9(6):476-84
2. Ahamad A, Stevens CW, Smythe WR, et al. Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2003;55(3):768-75
3. Allen AM, Czerminska M, Janne PA, et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys. 2006;65(3):640-45
4. Forster KM, Smythe WR, Starkschall G, et al. Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation. Int J Radiat Oncol Biol Phys. 2003;55(3):606-16
5. Allen AM, Schofield D, Hacker F, Court LE, and Czerminska M. Restricted field IMRT dramatically enhances IMRT planning for mesothelioma. Int J Radiat Oncol Biol Phys. 2007;69(5):1587-92
6. Stevens CW, Forster KM, Smythe WR, and Rice D. Radiotherapy for mesothelioma. Hematol Oncol Clin North Am. 2005;19(6):1099-115
7. Yorke ED, Jackson A, Rosenzweig KE, Braban L, Leibel SA, and Ling CC. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys. 2005;63(3):672-82
8. Alam R, Ibbott GS, Pourang R, and Nath R. Application of AAPM Radiation Therapy Committee Task Group 23 test package for comparison of two treatment planning systems for photon external beam radiotherapy. Med Phys. 1997;24(12):2043-54
9. Chow JC, Wong E, Chen JZ, and Van Dyk J. Comparison of dose calculation algorithms with Monte Carlo methods for photon arcs. Med Phys. 2003;30(10):2686-94
10. Ekstrand KE, and Barnes WH. Pitfalls in the use of high energy X rays to treat tumors in the lung. Int J Radiat Oncol Biol Phys. 1990;18(1):249-52
11. Epp ER, Boyer AL, and Doppke KP. Underdosing of lesions resulting from lack of electronic equilibrium in upper respiratory air cavities irradiated by 10MV x-ray beams. Int J Radiat Oncol Biol Phys. 1977;2(7-8):613-19
12. García-Vicente F, Miñambres A, Jerez I, Modolell I, Pérez L, and Torres JJ. Experimental validation tests of fast Fourier transform convolution and multigrid superposition algorithms for dose calculation in low-density media. Radiother Oncol. 2003;67(2):239-49
13. Hunt MA, Desobry GE, Fowble B, and Coia LR. Effect of low-density lateral interfaces on soft-tissue doses. Int J Radiat Oncol Biol Phys. 2997;37(2):475-82
14. Jones AO, Das IJ, and Jones FL Jr. A Monte Carlo study of IMRT beamlets in inhomogeneous media. Med Phys. 2003;30(3):296-300
15. Klein EE, Chin LM, Rice RK, and Mijnheer BJ. The influence of air cavities on interface doses for photon beams. Int J Radiat Oncol Biol Phys. 1993;27(2):419-27
16. White PJ, Zwicker RD, and Huang DT. Comparison of dose homogeneity effects due to electron equilibrium loss in lung for 6 MV and 18 MV photons. Int J Radiat Oncol Biol Phys. 1996;34(5):1141-46
17. Court LE, Jahnke L, Chin D, et al. Dynamic IMRT treatments of sinus region tumors: comparison of Monte Carlo calculations with treatment planning system calculations and ion chamber measurements. Technol Cancer Res Treat. 2006;5(5):489-95
18. Jang SY, Liu HH, Wang X, et al. Dosimetric verification for intensity-modulated radiotherapy of thoracic cancers using experimental and Monte Carlo approaches. Int J Radiat Oncol Biol Phys. 2006;66(3):939-48
19. Kry SF, Salehpour M, Followill DS, et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2005;62(4):1195-203
20. Kry SF, Titt U, Pönisch F, et al. A Monte Carlo model for calculating out-of-field dose from a varian 6 MV beam. Med Phys. 2006;33(11):4405-13
21. Rogers DW, Faddegon BA, Ding GX, Ma CM, We J, and Mackie TR. BEAM: a Monte Carlo code to simulate radiotherapy treatment units. Med Phys. 1995;22(5):503-24
22. Heath E and Seuntjens J. Development and validation of a BEAMnrc component module for accurate Monte Carlo modelling of the Varian dynamic Millennium multileaf collimator. Phys Med Biol. 2003;48(24):4045-63
23. Francescon P, Cavedon C, Reccanello S, and Cora S. Photon dose calculation of a three-dimensional treatment planning system compared to the Monte Carlo code BEAM. Med Phys. 2000;27(7):1579-87
24. Ma CM, Mok E, Kapur A, et al. Clinical implementation of a Monte Carlo treatment planning system. Med Phys. 1999;26(10):2133-43
25. Siebers JV, Keall PJ, Nahum AE, and Mohan R. Converting absorbed dose to medium to absorbed dose to water for Monte Carlo based photon beam dose calculations. Phys Med Biol. 2000;45(4):983-95
26. Murshed H, Liu HH, Liao Z, et al. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;58(4):1258-67
27. Yom SS, Liao A, Liu HH, et al. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68(1):94-102
28. De Neve W and De Wagter C. Lethal pneumonitis in a phase I study of chemotherapy and IMRT for NSCLC: the need to investigate the accuracy of dose computation. Radiother Oncol. 2005;75(2):246-47
29. Holloway CL, Robinson D, Murray B, et al. Results of a phase I study to dose escalate using intensity modulated radiotherapy guided by combined PET/CT imaging with induction chemotherapy for patients with non-small cell lung cancer. Radiother Oncol. 2004;73(3):285-87